Fatty liver disease (MASLD/MASH): open trials in Australia

10 open trials have a site in Australia. Registry data; only the trial team decides who can take part.

NCT05945537
A Study of INI-822 in Healthy Volunteers and Participants With Metabolic Dysfunction-Associated Steatohepatitis (MASH) or Presumed MASH
Trial Treatment · Phase 1 · Inipharm Australia Pty Ltd
Flinders Medical Centre, Flinders Medical Centre, Flinders, Bedford Park · University of the Sunshine Coast Clinical Trials (Birtinya), UniSC Clinical Trials Vitality Village, Level 4, Tenancy 410, 5 Discovery Court, Birtinya · Box Hill Hospital, Level 1, 5 Arnold street, Box Hill · Campbelltown Hospital, Level 10, building A, Campbelltown Hospital, Therry Road,, Campbelltown · Royal Prince Alfred Hospital, Camperdown · St Vincent's Hospital Melbourne, Fitzroy · TrialsWest Pty Ltd, 90 Anstruther Road, Mandurah · Genesis Research Services, Ground Floor, 239/245 Denison Street Broadmeadow, Newcastle · TrialsWest Pty Ltd, 226 Main Street, Osborne Park · Ramsay Health North Shore, North Shore Private, 03 Westbourne Street, Saint Leonards · Westmead Hospital, Storr Liver Centre, Level 2, A/B Block, Westmead Hospital Corner Hawkesbury and Darcy Roads, Westmead · Princess Alexandra Hospital, Woolloongabba
Registry updated 2026-11-06
NCT06215716
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
Trial Treatment · Phase 3 · Akero Therapeutics, Inc
Adelaide · Broadmeadow · Caulfield South · Coffs Harbour · Epping · Frankston · Heidelberg · Kogarah · Liverpool · Melbourne · Murdoch · Nedlands · Penrith · Perth · Westmead
Registry updated 2026-11-06
NCT06632444
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
Trial Treatment · Phase 3 · Boehringer Ingelheim
Sunshine Coast University Hospital, Birtinya · Monash Health, Clayton · Concord Repatriation General Hospital, Concord · Austin Health, Heidelberg · Nepean Hospital, Kingswood · Liverpool Hospital, Liverpool · Royal Melbourne Hospital, Parkville · Royal Perth Hospital, Perth · Westmead Hospital, Westmead
Registry updated 2026-10-28
NCT06632457
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
Trial Treatment · Phase 3 · Boehringer Ingelheim
Monash Health, Clayton · Concord Repatriation General Hospital, Concord · Austin Health, Heidelberg · Nepean Hospital, Kingswood · Liverpool Hospital, Liverpool · Royal Melbourne Hospital, Parkville · Royal Perth Hospital, Perth · Westmead Hospital, Westmead
Registry updated 2026-10-28
NCT06318169
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Trial Treatment · Phase 3 · Hoffmann-La Roche
Adelaide · Bedford Park · Brisbane · Clayton · Fitzroy · Heidelberg · Herston · Murdoch · Perth · South Brisbane
Registry updated 2026-10-23
NCT06419374
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Trial Treatment · Phase 3 · Hoffmann-La Roche
Adelaide · Fitzroy · Greenslopes · Heidelberg · Herston · Murdoch · Perth · South Brisbane
Registry updated 2026-10-23
NCT06528314
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Trial Treatment · Phase 3 · Akero Therapeutics, Inc
Adelaide · Box Hill · Broadmeadow · Clayton · Coffs Harbour · Epping · Heidelberg · Herston · Kingswood · Liverpool · Melbourne · Murdoch · Nedlands · Perth · Westmead
Registry updated 2026-10-13
NCT07165028
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Trial Treatment · Phase 3 · Eli Lilly and Company
Nightingale Research, Adelaide · Flinders Medical Centre, Adelaide · Box Hill Hospital, Box Hill · Royal Brisbane and Women's Hospital, Brisbane · Core Research Group, Brisbane · Gallipoli Medical Research Ltd, Brisbane · Mater Misericordiae Limited, Brisbane · Genesis Research Services, Broadmeadow · Barwon Health, Geelong · Austin Health, Heidelberg · Ipswich Hospital, Ipswich · Fiona Stanley Hospital, Murdoch · TrialsWest - Osborne Park, Osborne Park · The Royal Melbourne Hospital, Parkville · Gold Coast University Hospital, Southport · Westmead Hospital, Westmead
Registry updated 2026-10-08
NCT07221188
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
Trial Treatment · Phase 3 · GlaxoSmithKline
Woolloongabba
Registry updated 2026-09-17
NCT07221227
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
Trial Treatment · Phase 3 · GlaxoSmithKline
Broadmeadow · Heidelberg
Registry updated 2026-07-27

All Fatty liver disease (MASLD/MASH) trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error